SYNH News and Press, Syneos Health Inc. From 05/25/23

MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha Anson to the newly created role of Global Head of Patient Diversity and Health Equity. In thi...

MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu, President, Sites and Patients, Syneos Health; Sayee Natarajan, CEO & Co-founder, RxData...

NEW YORK, NY / ACCESSWIRE / May 11, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Syneos Health, Inc. (NASDAQ:SYNH)'s ...

2023-05-10 15:06:34 ET Syneos Health ( NASDAQ: SYNH ) likely saw a lot of interest from bidders before its sale to a private equity consortium on Wednesday, though not many offers were made. "It was a very broad auction, meaning a lot of people came and took a look, but it wasn'...

2023-05-10 07:31:07 ET Syneos Health ( NASDAQ: SYNH ) is being acquired by a private equity consortium in a transaction valued at ~$7.1B, including outstanding debt. The consortium which consists of affiliates composed of Elliott Investment Management Patient Square Capital and ...

2023-05-10 07:20:22 ET Syneos Health press release ( NASDAQ: SYNH ): Q1 Non-GAAP EPS of $0.75 beats by $0.09 . Revenue of $1.36B (+1.5% Y/Y) beats by $80M . Adjusted EBITDA of $151.1 million for the three months ended March 31, 2023. For further details s...

Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year. Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses, $713.6 million for the ...

Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated bioph...

2023-05-09 17:56:08 ET Gainers: Upstart Holdings ( UPST ) +37% . Syneos Health ( SYNH ) +19% . LegalZoom ( LZ ) +13% . CarGurus ( CARG ) +11% . RxSight ( RXST ) +10% . Losers: Cutera ( CUTR ) -24% . TechTarget...

2023-05-09 17:55:11 ET Syneos Health ( NASDAQ: SYNH ) soared 19% in after hours trading on a report that a private equity consortium is in advanced talks to purchase the drug-research services company. Elliott Investment Management, Patient Square and Veritas Capital are i...